Yosipovitch, G., Lio, P., Rosmarin, D., Serra Baldrich, E., Carrascosa, J. M., Crane, H., . . . Zhong, J. (2025). Lebrikizumab Improved Itch Symptoms and Reduced Itch Interference on Sleep over 52 Weeks in Patients with Moderate-to-Severe Atopic Dermatitis in Two Phase 3 Trials.
Citación estilo ChicagoYosipovitch, Gil|||0000-0001-6303-1822, et al. Lebrikizumab Improved Itch Symptoms and Reduced Itch Interference On Sleep Over 52 Weeks in Patients With Moderate-to-Severe Atopic Dermatitis in Two Phase 3 Trials. 2025.
Cita MLAYosipovitch, Gil|||0000-0001-6303-1822, et al. Lebrikizumab Improved Itch Symptoms and Reduced Itch Interference On Sleep Over 52 Weeks in Patients With Moderate-to-Severe Atopic Dermatitis in Two Phase 3 Trials. 2025.